社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Shlee
IP属地:未知
+关注
帖子 · 66
帖子 · 66
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Shlee
Shlee
·
2021-12-27
Nice
EV stocks mixed in morning trading<blockquote>电动汽车股早盘涨跌互现</blockquote>
EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and
EV stocks mixed in morning trading<blockquote>电动汽车股早盘涨跌互现</blockquote>
看
2,422
回复
评论
点赞
5
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-23
Nice
Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar:由于12月交付量强劲,特斯拉第四季度销量预计将增长43%</blockquote>
Tesla Inc’s fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles
Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar:由于12月交付量强劲,特斯拉第四季度销量预计将增长43%</blockquote>
看
3,290
回复
评论
点赞
3
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-17
Nice
非常抱歉,此主贴已删除
看
3,065
回复
1
点赞
2
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-16
Nice
U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后,美国股市周四高开,纳斯达克综合指数上涨0.4%</blockquote>
U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%
U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后,美国股市周四高开,纳斯达克综合指数上涨0.4%</blockquote>
看
3,387
回复
评论
点赞
8
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-14
Nice
非常抱歉,此主贴已删除
看
3,566
回复
1
点赞
3
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-10
Beyond meat
3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12月值得买入的3只高增长股票</blockquote>
Now is a good time to be greedy and buy up these depressed stocks.
3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12月值得买入的3只高增长股票</blockquote>
看
1,959
回复
评论
点赞
1
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-11-23
Nice
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作,将其算法用于mRNA疫苗和疗法开发</blockquote>
BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作,将其算法用于mRNA疫苗和疗法开发</blockquote>
看
2,400
回复
评论
点赞
1
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-11-19
Nice
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>
看
2,158
回复
评论
点赞
3
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-11-16
[OMG]
非常抱歉,此主贴已删除
看
4,024
回复
评论
点赞
1
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-10-29
Yes!
非常抱歉,此主贴已删除
看
3,308
回复
1
点赞
5
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3573647345754035","uuid":"3573647345754035","gmtCreate":1610556776007,"gmtModify":1706620610298,"name":"Shlee","pinyin":"shlee","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":17,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696318694,"gmtCreate":1640617094472,"gmtModify":1640617232336,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696318694","repostId":"1139095230","repostType":4,"repost":{"id":"1139095230","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640615948,"share":"https://www.laohu8.com/m/news/1139095230?lang=zh_CN&edition=full","pubTime":"2021-12-27 22:39","market":"us","language":"en","title":"EV stocks mixed in morning trading<blockquote>电动汽车股早盘涨跌互现</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1139095230","media":"Tiger Newspress","summary":"EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and ","content":"<p>EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and 3%.While Lucid fell more than 4%.</p><p><blockquote>电动汽车股早盘涨跌互现。特斯拉、尼古拉、蔚来、小鹏汽车和理想汽车上涨1%至3%。而Lucid则下跌超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0c26aaadf8023ee7e2e15e128470dc48\" tg-width=\"417\" tg-height=\"660\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks mixed in morning trading<blockquote>电动汽车股早盘涨跌互现</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks mixed in morning trading<blockquote>电动汽车股早盘涨跌互现</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-27 22:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and 3%.While Lucid fell more than 4%.</p><p><blockquote>电动汽车股早盘涨跌互现。特斯拉、尼古拉、蔚来、小鹏汽车和理想汽车上涨1%至3%。而Lucid则下跌超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0c26aaadf8023ee7e2e15e128470dc48\" tg-width=\"417\" tg-height=\"660\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","RIVN":"Rivian Automotive, Inc.","FSR":"菲斯克","LCID":"Lucid Group Inc","NIO":"蔚来","TSLA":"特斯拉","LI":"理想汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139095230","content_text":"EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and 3%.While Lucid fell more than 4%.","news_type":1,"symbols_score_info":{"NIO":0.9,"NKLA":0.9,"TSLA":0.9,"GOEV":0.9,"LCID":0.9,"ARVL":0.9,"XPEV":0.9,"LI":0.9,"FSR":0.9,"RIVN":0.9}},"isVote":1,"tweetType":1,"viewCount":2422,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698075573,"gmtCreate":1640270565309,"gmtModify":1640270565416,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698075573","repostId":"1140408431","repostType":4,"repost":{"id":"1140408431","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640258815,"share":"https://www.laohu8.com/m/news/1140408431?lang=zh_CN&edition=full","pubTime":"2021-12-23 19:26","market":"us","language":"en","title":"Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar:由于12月交付量强劲,特斯拉第四季度销量预计将增长43%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1140408431","media":"Benzinga","summary":"Tesla Inc’s fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles ","content":"<p><b>Tesla Inc’s</b> fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles from a year ago and 28.8% over the previous quarter, the latest automotive industry forecast from <b>TrueCar</b> reflected on Wednesday.</p><p><blockquote><b>特斯拉公司</b>根据最新的汽车行业预测,美国第四季度电动汽车销量预计将同比增长42.8%至97,417辆,环比增长28.8%<b>TrueCar</b>周三反映。</blockquote></p><p> <b>What Happened:</b>The <b>Elon Musk</b>-led company is expected to deliver 36,300 electric vehicles in the U.S. in December, a jump of 34.7% over last year and about 7% over November, according to TrueCar.</p><p><blockquote><b>发生了什么:</b>The<b>埃隆·马斯克</b>根据TrueCar的数据,这家以领先的公司预计12月份将在美国交付36,300辆电动汽车,比去年增长34.7%,比11月份增长约7%。</blockquote></p><p> Tesla sold 33,980 electric vehicles in November, the report noted.</p><p><blockquote>报告指出,特斯拉11月份售出了33,980辆电动汽车。</blockquote></p><p> Musk on Wednesday said Tesla is working hard to meet the year-end delivery targets as the electric vehicle maker company’s stock rejoined the $1-trillion-market-cap club.</p><p><blockquote>马斯克周三表示,随着这家电动汽车制造商的股票重新加入1万亿美元市值俱乐部,特斯拉正在努力实现年终交付目标。</blockquote></p><p> TrueCar also forecast total new vehicle sales will reach 1,144,108 units in December, down 27% from a year ago. The research agency estimated December’s seasonally adjusted annualized rate (SAAR) for total light-vehicle sales to be 11.9 million units, down 27% from a year ago.</p><p><blockquote>TrueCar还预测12月份新车总销量将达到1,144,108辆,同比下降27%。该研究机构估计,12月份轻型汽车总销量经季节调整后的年化率(SAAR)为1190万辆,同比下降27%。</blockquote></p><p> <b>How Will Legacy Players Fare?:</b>Both <b>General Motors Co</b> and <b>Ford Motor Co</b> are expected to report year-on-year declines in December sales due to the low base from a year ago when volumes were hit due to the pandemic and dealers were struggling with inventories.</p><p><blockquote><b>传统玩家的表现如何?:</b>两者<b>通用汽车公司</b>和<b>福特汽车公司</b>由于一年前的基数较低,预计12月份销售额将同比下降,当时销量因疫情而受到打击,经销商也在努力应对库存。</blockquote></p><p> The sales numbers are expected to rise over November for both GM and Ford.</p><p><blockquote>预计通用汽车和福特11月份的销量都将上升。</blockquote></p><p> GM’s December sales are expected to reach 168,640 vehicles, a decline of 42.9% on a year-on-year basis, and a rise of 21% over November.</p><p><blockquote>通用汽车12月销量预计将达到168,640辆,同比下降42.9%,比11月上涨21%。</blockquote></p><p> Ford is expected to report a decline of 20% to 166,547 vehicles in December, compared to a year ago, and a rise of 5.8% over last month.</p><p><blockquote>福特预计12月份汽车销量将同比下降20%,至166,547辆,环比增长5.8%。</blockquote></p><p> On a quarterly basis, Ford is expected to sell a total of 498,428 vehicles, a drop of 7.5% on a year-on-year basis but a rise of 25.3% over the third quarter.</p><p><blockquote>按季度计算,福特预计总销量为498,428辆,同比下降7.5%,但较第三季度增长25.3%。</blockquote></p><p> GM is expected to report total sales of 441,426 vehicles in the fourth quarter, implying declines of 42.5% year-on-year and down 0.4% quarter-on-quarter, the report noted.</p><p><blockquote>报告指出,通用汽车预计第四季度总销量为441,426辆,同比下降42.5%,环比下降0.4%。</blockquote></p><p> Historically, December has been a busy month for automakers as they rush to close the calendar year-end targets. This year, automakers around the world have been battling chip shortages to ensure a steady and timely supply to dealerships and customers. Legacy player Ford has earlier said it plans to keep inventories historically low.</p><p><blockquote>从历史上看,12月对于汽车制造商来说一直是忙碌的一个月,因为他们急于完成年终目标。今年,世界各地的汽车制造商一直在与芯片短缺作斗争,以确保向经销商和客户提供稳定、及时的供应。传统企业福特早些时候表示,计划将库存保持在历史低位。</blockquote></p><p> The report projected incentive spending in December to be down 55% from last year and 51% for the fourth quarter.</p><p><blockquote>该报告预计12月份的激励支出将比去年下降55%,第四季度下降51%。</blockquote></p><p> <b>Price Action:</b> Tesla shares closed 7.49% higher at $1,008.87 a share on Wednesday.</p><p><blockquote><b>价格走势:</b>特斯拉股价周三收盘上涨7.49%,至每股1008.87美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar:由于12月交付量强劲,特斯拉第四季度销量预计将增长43%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar:由于12月交付量强劲,特斯拉第四季度销量预计将增长43%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-12-23 19:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Tesla Inc’s</b> fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles from a year ago and 28.8% over the previous quarter, the latest automotive industry forecast from <b>TrueCar</b> reflected on Wednesday.</p><p><blockquote><b>特斯拉公司</b>根据最新的汽车行业预测,美国第四季度电动汽车销量预计将同比增长42.8%至97,417辆,环比增长28.8%<b>TrueCar</b>周三反映。</blockquote></p><p> <b>What Happened:</b>The <b>Elon Musk</b>-led company is expected to deliver 36,300 electric vehicles in the U.S. in December, a jump of 34.7% over last year and about 7% over November, according to TrueCar.</p><p><blockquote><b>发生了什么:</b>The<b>埃隆·马斯克</b>根据TrueCar的数据,这家以领先的公司预计12月份将在美国交付36,300辆电动汽车,比去年增长34.7%,比11月份增长约7%。</blockquote></p><p> Tesla sold 33,980 electric vehicles in November, the report noted.</p><p><blockquote>报告指出,特斯拉11月份售出了33,980辆电动汽车。</blockquote></p><p> Musk on Wednesday said Tesla is working hard to meet the year-end delivery targets as the electric vehicle maker company’s stock rejoined the $1-trillion-market-cap club.</p><p><blockquote>马斯克周三表示,随着这家电动汽车制造商的股票重新加入1万亿美元市值俱乐部,特斯拉正在努力实现年终交付目标。</blockquote></p><p> TrueCar also forecast total new vehicle sales will reach 1,144,108 units in December, down 27% from a year ago. The research agency estimated December’s seasonally adjusted annualized rate (SAAR) for total light-vehicle sales to be 11.9 million units, down 27% from a year ago.</p><p><blockquote>TrueCar还预测12月份新车总销量将达到1,144,108辆,同比下降27%。该研究机构估计,12月份轻型汽车总销量经季节调整后的年化率(SAAR)为1190万辆,同比下降27%。</blockquote></p><p> <b>How Will Legacy Players Fare?:</b>Both <b>General Motors Co</b> and <b>Ford Motor Co</b> are expected to report year-on-year declines in December sales due to the low base from a year ago when volumes were hit due to the pandemic and dealers were struggling with inventories.</p><p><blockquote><b>传统玩家的表现如何?:</b>两者<b>通用汽车公司</b>和<b>福特汽车公司</b>由于一年前的基数较低,预计12月份销售额将同比下降,当时销量因疫情而受到打击,经销商也在努力应对库存。</blockquote></p><p> The sales numbers are expected to rise over November for both GM and Ford.</p><p><blockquote>预计通用汽车和福特11月份的销量都将上升。</blockquote></p><p> GM’s December sales are expected to reach 168,640 vehicles, a decline of 42.9% on a year-on-year basis, and a rise of 21% over November.</p><p><blockquote>通用汽车12月销量预计将达到168,640辆,同比下降42.9%,比11月上涨21%。</blockquote></p><p> Ford is expected to report a decline of 20% to 166,547 vehicles in December, compared to a year ago, and a rise of 5.8% over last month.</p><p><blockquote>福特预计12月份汽车销量将同比下降20%,至166,547辆,环比增长5.8%。</blockquote></p><p> On a quarterly basis, Ford is expected to sell a total of 498,428 vehicles, a drop of 7.5% on a year-on-year basis but a rise of 25.3% over the third quarter.</p><p><blockquote>按季度计算,福特预计总销量为498,428辆,同比下降7.5%,但较第三季度增长25.3%。</blockquote></p><p> GM is expected to report total sales of 441,426 vehicles in the fourth quarter, implying declines of 42.5% year-on-year and down 0.4% quarter-on-quarter, the report noted.</p><p><blockquote>报告指出,通用汽车预计第四季度总销量为441,426辆,同比下降42.5%,环比下降0.4%。</blockquote></p><p> Historically, December has been a busy month for automakers as they rush to close the calendar year-end targets. This year, automakers around the world have been battling chip shortages to ensure a steady and timely supply to dealerships and customers. Legacy player Ford has earlier said it plans to keep inventories historically low.</p><p><blockquote>从历史上看,12月对于汽车制造商来说一直是忙碌的一个月,因为他们急于完成年终目标。今年,世界各地的汽车制造商一直在与芯片短缺作斗争,以确保向经销商和客户提供稳定、及时的供应。传统企业福特早些时候表示,计划将库存保持在历史低位。</blockquote></p><p> The report projected incentive spending in December to be down 55% from last year and 51% for the fourth quarter.</p><p><blockquote>该报告预计12月份的激励支出将比去年下降55%,第四季度下降51%。</blockquote></p><p> <b>Price Action:</b> Tesla shares closed 7.49% higher at $1,008.87 a share on Wednesday.</p><p><blockquote><b>价格走势:</b>特斯拉股价周三收盘上涨7.49%,至每股1008.87美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140408431","content_text":"Tesla Inc’s fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles from a year ago and 28.8% over the previous quarter, the latest automotive industry forecast from TrueCar reflected on Wednesday.\nWhat Happened:The Elon Musk-led company is expected to deliver 36,300 electric vehicles in the U.S. in December, a jump of 34.7% over last year and about 7% over November, according to TrueCar.\nTesla sold 33,980 electric vehicles in November, the report noted.\nMusk on Wednesday said Tesla is working hard to meet the year-end delivery targets as the electric vehicle maker company’s stock rejoined the $1-trillion-market-cap club.\nTrueCar also forecast total new vehicle sales will reach 1,144,108 units in December, down 27% from a year ago. The research agency estimated December’s seasonally adjusted annualized rate (SAAR) for total light-vehicle sales to be 11.9 million units, down 27% from a year ago.\nHow Will Legacy Players Fare?:Both General Motors Co and Ford Motor Co are expected to report year-on-year declines in December sales due to the low base from a year ago when volumes were hit due to the pandemic and dealers were struggling with inventories.\nThe sales numbers are expected to rise over November for both GM and Ford.\nGM’s December sales are expected to reach 168,640 vehicles, a decline of 42.9% on a year-on-year basis, and a rise of 21% over November.\nFord is expected to report a decline of 20% to 166,547 vehicles in December, compared to a year ago, and a rise of 5.8% over last month.\nOn a quarterly basis, Ford is expected to sell a total of 498,428 vehicles, a drop of 7.5% on a year-on-year basis but a rise of 25.3% over the third quarter.\nGM is expected to report total sales of 441,426 vehicles in the fourth quarter, implying declines of 42.5% year-on-year and down 0.4% quarter-on-quarter, the report noted.\nHistorically, December has been a busy month for automakers as they rush to close the calendar year-end targets. This year, automakers around the world have been battling chip shortages to ensure a steady and timely supply to dealerships and customers. Legacy player Ford has earlier said it plans to keep inventories historically low.\nThe report projected incentive spending in December to be down 55% from last year and 51% for the fourth quarter.\nPrice Action: Tesla shares closed 7.49% higher at $1,008.87 a share on Wednesday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699118924,"gmtCreate":1639755143620,"gmtModify":1639755143863,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699118924","repostId":"2192462941","repostType":2,"isVote":1,"tweetType":1,"viewCount":3065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690648910,"gmtCreate":1639666223435,"gmtModify":1639666223552,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690648910","repostId":"1103611253","repostType":4,"repost":{"id":"1103611253","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639665157,"share":"https://www.laohu8.com/m/news/1103611253?lang=zh_CN&edition=full","pubTime":"2021-12-16 22:32","market":"us","language":"en","title":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后,美国股市周四高开,纳斯达克综合指数上涨0.4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1103611253","media":"Tiger Newspress","summary":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%","content":"<p>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.</p><p><blockquote>继周三美联储日反弹后,美国股市周四高开,纳斯达克综合指数上涨0.4%,道指上涨0.5%;周四早盘,标普500上涨0.4%,标普500股价创历史新高。</blockquote></p><p> Shares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.</p><p><blockquote>在之前的加息周期中表现良好的公司股价领涨盘前。材料股FMC Corp.和Freeport-McMoRan在开盘前均上涨超过3%。银行股也全线上涨,摩根大通、花旗和美国银行均上涨约0.6%。</blockquote></p><p> In transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.</p><p><blockquote>交通新闻方面,达美航空报告称,在此前预计亏损后,目前预计第四季度利润为2亿美元。受此消息影响,股价上涨2.2%。</blockquote></p><p> In other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.</p><p><blockquote>其他央行消息方面,英国央行宣布将关键政策利率上调15个基点至0.25%。市场正在等待欧洲央行的单独政策决定。还有更多经济新闻,每周初请失业金人数和房屋开工时间将于美国东部时间上午8:30公布。</blockquote></p><p> Following the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.</p><p><blockquote>美联储消息传出后,交易员加速了自己对加息的预期。根据CME FedWatch工具的数据,联邦基金期货交易目前显示,2022年5月首次加息25个百分点的可能性为63%,央行最早在3月份采取第一步行动的可能性也升至约44%。</blockquote></p><p> Stocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.</p><p><blockquote>周三,股市在整个常规交易中均处于负值区域,并在美联储主席杰罗姆·鲍威尔下午在为期两天的联邦公开市场委员会会议结束时举行新闻发布会之前转为走高。道琼斯指数上涨383点,涨幅1.08%。标普500上涨1.63%,以科技股为主的纳斯达克综合指数上涨2.15%。</blockquote></p><p> “The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.</p><p><blockquote>“事实上,联邦公开市场委员会承认新的新冠病毒变种对经济复苏构成威胁,可能会改变未来的政策,以及鲍威尔在新闻发布会上普遍乐观的语气,帮助引发了缓解性反弹,因为美联储会议被视为不像人们担心的那么鹰派,”Sevens Report的汤姆·埃萨耶(Tom Essaye)在周四的一份报告中表示。</blockquote></p><p> The Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.</p><p><blockquote>美联储将从1月份开始放慢资产购买步伐,未来每月仅购买600亿美元的债券,而12月份为900亿美元。此前,近期通胀数据显示11月份通胀飙升6.8%,高于预期,也是1982年以来的最快增速。</blockquote></p><p> “The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.</p><p><blockquote>查理·里普利(Charlie Ripley)表示:“通胀水平上升将是暂时的观念最终被美联储抛到了九霄云外,最新的政策调整反映出委员会不想错过下一班离开车站的火车。”安联投资管理公司高级投资策略师。</blockquote></p><p> Corporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.</p><p><blockquote>周四,企业盈利似乎是市场的弱点,Adobe和Lennar的股价在季度报告表现不佳后在盘前交易中下跌。</blockquote></p><p> On the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.</p><p><blockquote>经济数据方面,每周申请失业救济人数略高于预期,而11月份新屋开工数在上月下降后远强于经济学家的预期。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后,美国股市周四高开,纳斯达克综合指数上涨0.4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后,美国股市周四高开,纳斯达克综合指数上涨0.4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 22:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.</p><p><blockquote>继周三美联储日反弹后,美国股市周四高开,纳斯达克综合指数上涨0.4%,道指上涨0.5%;周四早盘,标普500上涨0.4%,标普500股价创历史新高。</blockquote></p><p> Shares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.</p><p><blockquote>在之前的加息周期中表现良好的公司股价领涨盘前。材料股FMC Corp.和Freeport-McMoRan在开盘前均上涨超过3%。银行股也全线上涨,摩根大通、花旗和美国银行均上涨约0.6%。</blockquote></p><p> In transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.</p><p><blockquote>交通新闻方面,达美航空报告称,在此前预计亏损后,目前预计第四季度利润为2亿美元。受此消息影响,股价上涨2.2%。</blockquote></p><p> In other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.</p><p><blockquote>其他央行消息方面,英国央行宣布将关键政策利率上调15个基点至0.25%。市场正在等待欧洲央行的单独政策决定。还有更多经济新闻,每周初请失业金人数和房屋开工时间将于美国东部时间上午8:30公布。</blockquote></p><p> Following the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.</p><p><blockquote>美联储消息传出后,交易员加速了自己对加息的预期。根据CME FedWatch工具的数据,联邦基金期货交易目前显示,2022年5月首次加息25个百分点的可能性为63%,央行最早在3月份采取第一步行动的可能性也升至约44%。</blockquote></p><p> Stocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.</p><p><blockquote>周三,股市在整个常规交易中均处于负值区域,并在美联储主席杰罗姆·鲍威尔下午在为期两天的联邦公开市场委员会会议结束时举行新闻发布会之前转为走高。道琼斯指数上涨383点,涨幅1.08%。标普500上涨1.63%,以科技股为主的纳斯达克综合指数上涨2.15%。</blockquote></p><p> “The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.</p><p><blockquote>“事实上,联邦公开市场委员会承认新的新冠病毒变种对经济复苏构成威胁,可能会改变未来的政策,以及鲍威尔在新闻发布会上普遍乐观的语气,帮助引发了缓解性反弹,因为美联储会议被视为不像人们担心的那么鹰派,”Sevens Report的汤姆·埃萨耶(Tom Essaye)在周四的一份报告中表示。</blockquote></p><p> The Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.</p><p><blockquote>美联储将从1月份开始放慢资产购买步伐,未来每月仅购买600亿美元的债券,而12月份为900亿美元。此前,近期通胀数据显示11月份通胀飙升6.8%,高于预期,也是1982年以来的最快增速。</blockquote></p><p> “The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.</p><p><blockquote>查理·里普利(Charlie Ripley)表示:“通胀水平上升将是暂时的观念最终被美联储抛到了九霄云外,最新的政策调整反映出委员会不想错过下一班离开车站的火车。”安联投资管理公司高级投资策略师。</blockquote></p><p> Corporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.</p><p><blockquote>周四,企业盈利似乎是市场的弱点,Adobe和Lennar的股价在季度报告表现不佳后在盘前交易中下跌。</blockquote></p><p> On the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.</p><p><blockquote>经济数据方面,每周申请失业救济人数略高于预期,而11月份新屋开工数在上月下降后远强于经济学家的预期。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103611253","content_text":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.\nShares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.\nIn transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.\nIn other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.\nFollowing the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.\nStocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.\n“The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.\nThe Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.\n“The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.\nCorporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.\nOn the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":3387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607353417,"gmtCreate":1639492755940,"gmtModify":1639492763552,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607353417","repostId":"2191932169","repostType":2,"isVote":1,"tweetType":1,"viewCount":3566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605616949,"gmtCreate":1639151363801,"gmtModify":1639151363866,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Beyond meat","listText":"Beyond meat","text":"Beyond meat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605616949","repostId":"1147480652","repostType":2,"repost":{"id":"1147480652","kind":"news","pubTimestamp":1639125342,"share":"https://www.laohu8.com/m/news/1147480652?lang=zh_CN&edition=full","pubTime":"2021-12-10 16:35","market":"us","language":"en","title":"3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12月值得买入的3只高增长股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147480652","media":"Motley Fool","summary":"Now is a good time to be greedy and buy up these depressed stocks.","content":"<p>If you're looking to do some Christmas shopping on stocks, there are some incredibly good deals out there right now. The market isn't crashing, but some stocks have been struggling of late that you likely won't regret adding to your portfolio today if you're a long-term investor.</p><p><blockquote>如果您想在圣诞节购买股票,现在有一些非常划算的交易。市场并没有崩溃,但一些股票最近一直在苦苦挣扎,如果您是长期投资者,您可能不会后悔今天添加到您的投资组合中。</blockquote></p><p> Shares of <b>Jazz Pharmaceuticals</b>,<b>DocuSign</b>,and <b>Beyond Meat</b> haven't been this cheap in months. And all these businesses have the potential to generate some strong growth numbers in the months and years ahead, which could mean great returns for you.</p><p><blockquote>本公司之股份<b>爵士制药公司</b>,<b>DocuSign</b>,和<b>Beyond Meat</b>几个月没这么便宜了。所有这些业务都有潜力在未来几个月和几年内产生强劲的增长数字,这可能意味着您获得巨大的回报。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2aaa8c5069132f2d41beafbfbef0705f\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源:盖蒂图片社</span></p></blockquote></p><p> <b>1. Jazz Pharmaceuticals</b></p><p><blockquote><b>1.爵士制药</b></blockquote></p><p> Healthcare company Jazz Pharmaceuticals is trading around its 52-week low, down 25% year to date even as the <b>S&P 500</b> is up 22%. In February, the company announced it was acquiring GW Pharmaceuticals, which makes Epidiolex, a cannabis-based drug that treats seizures. Softness in the cannabis market (due to a disappointing pace in legalization) may in part be affecting the shares.</p><p><blockquote>医疗保健公司Jazz Pharmaceuticals的交易价格接近52周低点,今年迄今已下跌25%,尽管<b>标普500</b>上涨了22%。今年2月,该公司宣布收购GW Pharmaceuticals,该公司生产Epidiolex,一种治疗癫痫发作的大麻药物。大麻市场的疲软(由于合法化步伐令人失望)可能在一定程度上影响了股价。</blockquote></p><p> Yet, the company still has promise. Jazz reported its latest quarterly results in November, and revenue rose 39% year over year to $838 million. Over half of that came from products that were either new or just acquired, such as Epidiolex. Its sales rose a robust 21% despite investor concerns.</p><p><blockquote>然而,该公司仍然有希望。Jazz于11月公布了最新季度业绩,收入同比增长39%至8.38亿美元。其中一半以上来自新产品或刚刚收购的产品,例如Epidiolex。尽管投资者感到担忧,但其销售额仍强劲增长了21%。</blockquote></p><p> In fact, Epidiolex is what makes Jazz a promising buy here as the company is looking at new indications for it; plus, it is rolling out Epidiolex to new countries in Europe. Both moves could bolster the drug's sales over the long term.</p><p><blockquote>事实上,Epidiolex使Jazz成为一个有前途的买家,因为该公司正在寻找新的适应症;此外,它还将Epidiolex推广到欧洲的新国家。从长远来看,这两项举措都可能提振该药物的销售。</blockquote></p><p> Prospects for long-term profitability also look strong. The company has generated impressive gross margins of 82% or better in each of the past four quarters. Although its bottom line has fallen into the red after the acquisition of GW Pharma, that's not where investors should expect the company to stay. Jazz could be a steal of a deal right now.</p><p><blockquote>长期盈利前景看起来也很强劲。该公司在过去四个季度每个季度的毛利率都达到了82%或更高,令人印象深刻。尽管在收购GW Pharma后,其利润已陷入亏损,但这并不是投资者对该公司的预期。爵士乐现在可能是一笔划算的交易。</blockquote></p><p> <b>2. DocuSign</b></p><p><blockquote><b>2.DocuSign</b></blockquote></p><p> Anytime a stock falls more than 40% in a <i>single day</i>, it's worth asking whether the market overreacted. That's what looks to have happened with DocuSign. The company beat expectations when it reported third-quarter results last week. Sales for the period ended Oct. 31 soared 42% year over year to $545.5 million. The company also regularly boasts a gross profit of close to 80%.</p><p><blockquote>每当股票在一年内下跌超过40%时<i>单日</i>,值得追问的是市场是否反应过度。DocuSign似乎就是这样。该公司上周公布第三季度业绩超出预期。截至10月31日的期间销售额同比飙升42%至5.455亿美元。该公司的毛利润也经常接近80%。</blockquote></p><p> Yet, that wasn't enough for investors. A sell-off ensued as the tech company provided fourth-quarter revenue guidance of $557 million to $563 million -- and that fell well shy of the $574 million that analysts were expecting. While the estimate is below analysts' figures, that hardly seems to be a reason to warrant such an incredible drop in price.</p><p><blockquote>然而,这对投资者来说还不够。随着这家科技公司提供的第四季度收入指引为5.57亿美元至5.63亿美元,远低于分析师预期的5.74亿美元,抛售随之而来。虽然这一估计低于分析师的数据,但这似乎很难成为价格如此令人难以置信的下跌的理由。</blockquote></p><p> Unfortunately, in the era of meme stocks, where companies with questionable growth prospects such as <b>AMC Entertainment</b> can skyrocket over 1,000% -- mainly on hype from retail investors -- high-quality businesses like DocuSign can also fall drastically without a good reason. Such a steep sell-off due to one quarter's guidance is the epitome of short-term thinking.</p><p><blockquote>不幸的是,在模因股票时代,增长前景值得怀疑的公司,例如<b>AMC院线</b>可以飙升超过1,000%——主要是由于散户投资者的炒作——像DocuSign这样的优质企业也可能在没有充分理由的情况下大幅下跌。由于一个季度的指引而出现如此急剧的抛售,是短期思维的缩影。</blockquote></p><p> DocuSign will likely see demand subside a bit as people return to the office and are no longer relying as much on digital signatures. However, that doesn't mean its growth is over. Analysts from Fortune Business Insights project that the global digital signature market will grow at a compound annual rate of 28.9% through 2027.</p><p><blockquote>随着人们回到办公室,不再那么依赖数字签名,DocuSign的需求可能会有所下降。然而,这并不意味着它的增长已经结束。Fortune Business Insights分析师预计,到2027年,全球数字签名市场将以28.9%的复合年增长率增长。</blockquote></p><p> So despite the bearishness, the sky isn't falling for DocuSign, and it looks like it could be a bargain buy right now. Although the stock has bounced up from the lows it hit last week, it's still around levels not seen since June 2020.</p><p><blockquote>因此,尽管存在看跌情绪,但DocuSign的天并没有塌下来,看起来现在可能是一个便宜货。尽管该股已从上周触及的低点反弹,但仍处于2020年6月以来的最高水平附近。</blockquote></p><p> <b>3. Beyond Meat</b></p><p><blockquote><b>3.Beyond Meat</b></blockquote></p><p> Another stock that has struggled after releasing earnings is Beyond Meat. At just over $70, the stock is trading near its 52-week lows, having fallen 43% this year.It's not a huge surprise given that the company has an unfortunate trend of missing earnings expectations. Yet, Beyond Meat is a great recovery stock to own as economies see a return to normal and COVID-19 no longer impacts demand for its products or disrupts the supply chain.</p><p><blockquote>另一只在发布财报后陷入困境的股票是Beyond Meat。该股股价略高于70美元,接近52周低点,今年已下跌43%。鉴于该公司有未达到盈利预期的不幸趋势,这并不令人意外。然而,随着经济恢复正常,COVID-19不再影响对其产品的需求或扰乱供应链,Beyond Meat是一只值得持有的复苏股票。</blockquote></p><p> In 2019, the company's sales of $298 million were more than triple the $88 million it reported in 2018. And in 2020, sales rose further to $407 million but at a much lower growth rate of 37%. For the latest quarter ended Oct. 2, net revenue increased just 13% to $106 million -- and in the U.S. market, sales were actually down 14%. It was the company's international operations that kept the overall numbers in the green (rising by an impressive 143%).</p><p><blockquote>2019年,该公司的销售额为2.98亿美元,是2018年8800万美元的三倍多。2020年,销售额进一步上升至4.07亿美元,但增长率低得多,为37%。截至10月2日的最新季度,净收入仅增长13%,达到1.06亿美元,而在美国市场,销售额实际上下降了14%。正是该公司的国际业务使整体数字保持绿色(增长了令人印象深刻的143%)。</blockquote></p><p></p><p> However, the company's performance should improve with a return to normalcy. In addition, Beyond Meat has new products and deals that could propel it to even greater heights than before. It is supplying fast-food giant <b>McDonald's</b> with the patty for its McPlant burger, which could be a boon for the business if it proves to be successful. Plus, it has a joint venture with soft-drink maker <b>PepsiCo</b> to develop new products. Beyond Meat also recently launched meatless chicken tenders.</p><p><blockquote>然而,随着恢复正常,该公司的业绩应该会有所改善。此外,Beyond Meat的新产品和交易可能会将其推向比以前更高的高度。它正在供应快餐巨头<b>麦当劳</b>McPlant汉堡的肉饼,如果被证明是成功的,这可能会给企业带来福音。此外,它还与软饮料制造商成立了一家合资企业<b>百事可乐</b>开发新产品。Beyond Meat最近也推出了无肉鸡柳。</blockquote></p><p> Things may look grim in the short term for Beyond Meat, but there are many catalysts out there that could make its stock price today look incredibly cheap in a year or two.</p><p><blockquote>对于Beyond Meat来说,短期内的情况可能看起来很严峻,但有许多催化剂可能会使其今天的股价在一两年内看起来非常便宜。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12月值得买入的3只高增长股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12月值得买入的3只高增长股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-10 16:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>If you're looking to do some Christmas shopping on stocks, there are some incredibly good deals out there right now. The market isn't crashing, but some stocks have been struggling of late that you likely won't regret adding to your portfolio today if you're a long-term investor.</p><p><blockquote>如果您想在圣诞节购买股票,现在有一些非常划算的交易。市场并没有崩溃,但一些股票最近一直在苦苦挣扎,如果您是长期投资者,您可能不会后悔今天添加到您的投资组合中。</blockquote></p><p> Shares of <b>Jazz Pharmaceuticals</b>,<b>DocuSign</b>,and <b>Beyond Meat</b> haven't been this cheap in months. And all these businesses have the potential to generate some strong growth numbers in the months and years ahead, which could mean great returns for you.</p><p><blockquote>本公司之股份<b>爵士制药公司</b>,<b>DocuSign</b>,和<b>Beyond Meat</b>几个月没这么便宜了。所有这些业务都有潜力在未来几个月和几年内产生强劲的增长数字,这可能意味着您获得巨大的回报。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2aaa8c5069132f2d41beafbfbef0705f\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源:盖蒂图片社</span></p></blockquote></p><p> <b>1. Jazz Pharmaceuticals</b></p><p><blockquote><b>1.爵士制药</b></blockquote></p><p> Healthcare company Jazz Pharmaceuticals is trading around its 52-week low, down 25% year to date even as the <b>S&P 500</b> is up 22%. In February, the company announced it was acquiring GW Pharmaceuticals, which makes Epidiolex, a cannabis-based drug that treats seizures. Softness in the cannabis market (due to a disappointing pace in legalization) may in part be affecting the shares.</p><p><blockquote>医疗保健公司Jazz Pharmaceuticals的交易价格接近52周低点,今年迄今已下跌25%,尽管<b>标普500</b>上涨了22%。今年2月,该公司宣布收购GW Pharmaceuticals,该公司生产Epidiolex,一种治疗癫痫发作的大麻药物。大麻市场的疲软(由于合法化步伐令人失望)可能在一定程度上影响了股价。</blockquote></p><p> Yet, the company still has promise. Jazz reported its latest quarterly results in November, and revenue rose 39% year over year to $838 million. Over half of that came from products that were either new or just acquired, such as Epidiolex. Its sales rose a robust 21% despite investor concerns.</p><p><blockquote>然而,该公司仍然有希望。Jazz于11月公布了最新季度业绩,收入同比增长39%至8.38亿美元。其中一半以上来自新产品或刚刚收购的产品,例如Epidiolex。尽管投资者感到担忧,但其销售额仍强劲增长了21%。</blockquote></p><p> In fact, Epidiolex is what makes Jazz a promising buy here as the company is looking at new indications for it; plus, it is rolling out Epidiolex to new countries in Europe. Both moves could bolster the drug's sales over the long term.</p><p><blockquote>事实上,Epidiolex使Jazz成为一个有前途的买家,因为该公司正在寻找新的适应症;此外,它还将Epidiolex推广到欧洲的新国家。从长远来看,这两项举措都可能提振该药物的销售。</blockquote></p><p> Prospects for long-term profitability also look strong. The company has generated impressive gross margins of 82% or better in each of the past four quarters. Although its bottom line has fallen into the red after the acquisition of GW Pharma, that's not where investors should expect the company to stay. Jazz could be a steal of a deal right now.</p><p><blockquote>长期盈利前景看起来也很强劲。该公司在过去四个季度每个季度的毛利率都达到了82%或更高,令人印象深刻。尽管在收购GW Pharma后,其利润已陷入亏损,但这并不是投资者对该公司的预期。爵士乐现在可能是一笔划算的交易。</blockquote></p><p> <b>2. DocuSign</b></p><p><blockquote><b>2.DocuSign</b></blockquote></p><p> Anytime a stock falls more than 40% in a <i>single day</i>, it's worth asking whether the market overreacted. That's what looks to have happened with DocuSign. The company beat expectations when it reported third-quarter results last week. Sales for the period ended Oct. 31 soared 42% year over year to $545.5 million. The company also regularly boasts a gross profit of close to 80%.</p><p><blockquote>每当股票在一年内下跌超过40%时<i>单日</i>,值得追问的是市场是否反应过度。DocuSign似乎就是这样。该公司上周公布第三季度业绩超出预期。截至10月31日的期间销售额同比飙升42%至5.455亿美元。该公司的毛利润也经常接近80%。</blockquote></p><p> Yet, that wasn't enough for investors. A sell-off ensued as the tech company provided fourth-quarter revenue guidance of $557 million to $563 million -- and that fell well shy of the $574 million that analysts were expecting. While the estimate is below analysts' figures, that hardly seems to be a reason to warrant such an incredible drop in price.</p><p><blockquote>然而,这对投资者来说还不够。随着这家科技公司提供的第四季度收入指引为5.57亿美元至5.63亿美元,远低于分析师预期的5.74亿美元,抛售随之而来。虽然这一估计低于分析师的数据,但这似乎很难成为价格如此令人难以置信的下跌的理由。</blockquote></p><p> Unfortunately, in the era of meme stocks, where companies with questionable growth prospects such as <b>AMC Entertainment</b> can skyrocket over 1,000% -- mainly on hype from retail investors -- high-quality businesses like DocuSign can also fall drastically without a good reason. Such a steep sell-off due to one quarter's guidance is the epitome of short-term thinking.</p><p><blockquote>不幸的是,在模因股票时代,增长前景值得怀疑的公司,例如<b>AMC院线</b>可以飙升超过1,000%——主要是由于散户投资者的炒作——像DocuSign这样的优质企业也可能在没有充分理由的情况下大幅下跌。由于一个季度的指引而出现如此急剧的抛售,是短期思维的缩影。</blockquote></p><p> DocuSign will likely see demand subside a bit as people return to the office and are no longer relying as much on digital signatures. However, that doesn't mean its growth is over. Analysts from Fortune Business Insights project that the global digital signature market will grow at a compound annual rate of 28.9% through 2027.</p><p><blockquote>随着人们回到办公室,不再那么依赖数字签名,DocuSign的需求可能会有所下降。然而,这并不意味着它的增长已经结束。Fortune Business Insights分析师预计,到2027年,全球数字签名市场将以28.9%的复合年增长率增长。</blockquote></p><p> So despite the bearishness, the sky isn't falling for DocuSign, and it looks like it could be a bargain buy right now. Although the stock has bounced up from the lows it hit last week, it's still around levels not seen since June 2020.</p><p><blockquote>因此,尽管存在看跌情绪,但DocuSign的天并没有塌下来,看起来现在可能是一个便宜货。尽管该股已从上周触及的低点反弹,但仍处于2020年6月以来的最高水平附近。</blockquote></p><p> <b>3. Beyond Meat</b></p><p><blockquote><b>3.Beyond Meat</b></blockquote></p><p> Another stock that has struggled after releasing earnings is Beyond Meat. At just over $70, the stock is trading near its 52-week lows, having fallen 43% this year.It's not a huge surprise given that the company has an unfortunate trend of missing earnings expectations. Yet, Beyond Meat is a great recovery stock to own as economies see a return to normal and COVID-19 no longer impacts demand for its products or disrupts the supply chain.</p><p><blockquote>另一只在发布财报后陷入困境的股票是Beyond Meat。该股股价略高于70美元,接近52周低点,今年已下跌43%。鉴于该公司有未达到盈利预期的不幸趋势,这并不令人意外。然而,随着经济恢复正常,COVID-19不再影响对其产品的需求或扰乱供应链,Beyond Meat是一只值得持有的复苏股票。</blockquote></p><p> In 2019, the company's sales of $298 million were more than triple the $88 million it reported in 2018. And in 2020, sales rose further to $407 million but at a much lower growth rate of 37%. For the latest quarter ended Oct. 2, net revenue increased just 13% to $106 million -- and in the U.S. market, sales were actually down 14%. It was the company's international operations that kept the overall numbers in the green (rising by an impressive 143%).</p><p><blockquote>2019年,该公司的销售额为2.98亿美元,是2018年8800万美元的三倍多。2020年,销售额进一步上升至4.07亿美元,但增长率低得多,为37%。截至10月2日的最新季度,净收入仅增长13%,达到1.06亿美元,而在美国市场,销售额实际上下降了14%。正是该公司的国际业务使整体数字保持绿色(增长了令人印象深刻的143%)。</blockquote></p><p></p><p> However, the company's performance should improve with a return to normalcy. In addition, Beyond Meat has new products and deals that could propel it to even greater heights than before. It is supplying fast-food giant <b>McDonald's</b> with the patty for its McPlant burger, which could be a boon for the business if it proves to be successful. Plus, it has a joint venture with soft-drink maker <b>PepsiCo</b> to develop new products. Beyond Meat also recently launched meatless chicken tenders.</p><p><blockquote>然而,随着恢复正常,该公司的业绩应该会有所改善。此外,Beyond Meat的新产品和交易可能会将其推向比以前更高的高度。它正在供应快餐巨头<b>麦当劳</b>McPlant汉堡的肉饼,如果被证明是成功的,这可能会给企业带来福音。此外,它还与软饮料制造商成立了一家合资企业<b>百事可乐</b>开发新产品。Beyond Meat最近也推出了无肉鸡柳。</blockquote></p><p> Things may look grim in the short term for Beyond Meat, but there are many catalysts out there that could make its stock price today look incredibly cheap in a year or two.</p><p><blockquote>对于Beyond Meat来说,短期内的情况可能看起来很严峻,但有许多催化剂可能会使其今天的股价在一两年内看起来非常便宜。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/12/09/3-high-growth-stocks-that-are-screaming-buys-in-de/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DOCU":"Docusign","JAZZ":"爵士制药","BYND":"Beyond Meat, Inc."},"source_url":"https://www.fool.com/investing/2021/12/09/3-high-growth-stocks-that-are-screaming-buys-in-de/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147480652","content_text":"If you're looking to do some Christmas shopping on stocks, there are some incredibly good deals out there right now. The market isn't crashing, but some stocks have been struggling of late that you likely won't regret adding to your portfolio today if you're a long-term investor.\nShares of Jazz Pharmaceuticals,DocuSign,and Beyond Meat haven't been this cheap in months. And all these businesses have the potential to generate some strong growth numbers in the months and years ahead, which could mean great returns for you.\nImage source: Getty Images\n1. Jazz Pharmaceuticals\nHealthcare company Jazz Pharmaceuticals is trading around its 52-week low, down 25% year to date even as the S&P 500 is up 22%. In February, the company announced it was acquiring GW Pharmaceuticals, which makes Epidiolex, a cannabis-based drug that treats seizures. Softness in the cannabis market (due to a disappointing pace in legalization) may in part be affecting the shares.\nYet, the company still has promise. Jazz reported its latest quarterly results in November, and revenue rose 39% year over year to $838 million. Over half of that came from products that were either new or just acquired, such as Epidiolex. Its sales rose a robust 21% despite investor concerns.\nIn fact, Epidiolex is what makes Jazz a promising buy here as the company is looking at new indications for it; plus, it is rolling out Epidiolex to new countries in Europe. Both moves could bolster the drug's sales over the long term.\nProspects for long-term profitability also look strong. The company has generated impressive gross margins of 82% or better in each of the past four quarters. Although its bottom line has fallen into the red after the acquisition of GW Pharma, that's not where investors should expect the company to stay. Jazz could be a steal of a deal right now.\n2. DocuSign\nAnytime a stock falls more than 40% in a single day, it's worth asking whether the market overreacted. That's what looks to have happened with DocuSign. The company beat expectations when it reported third-quarter results last week. Sales for the period ended Oct. 31 soared 42% year over year to $545.5 million. The company also regularly boasts a gross profit of close to 80%.\nYet, that wasn't enough for investors. A sell-off ensued as the tech company provided fourth-quarter revenue guidance of $557 million to $563 million -- and that fell well shy of the $574 million that analysts were expecting. While the estimate is below analysts' figures, that hardly seems to be a reason to warrant such an incredible drop in price.\nUnfortunately, in the era of meme stocks, where companies with questionable growth prospects such as AMC Entertainment can skyrocket over 1,000% -- mainly on hype from retail investors -- high-quality businesses like DocuSign can also fall drastically without a good reason. Such a steep sell-off due to one quarter's guidance is the epitome of short-term thinking.\nDocuSign will likely see demand subside a bit as people return to the office and are no longer relying as much on digital signatures. However, that doesn't mean its growth is over. Analysts from Fortune Business Insights project that the global digital signature market will grow at a compound annual rate of 28.9% through 2027.\nSo despite the bearishness, the sky isn't falling for DocuSign, and it looks like it could be a bargain buy right now. Although the stock has bounced up from the lows it hit last week, it's still around levels not seen since June 2020.\n3. Beyond Meat\nAnother stock that has struggled after releasing earnings is Beyond Meat. At just over $70, the stock is trading near its 52-week lows, having fallen 43% this year.It's not a huge surprise given that the company has an unfortunate trend of missing earnings expectations. Yet, Beyond Meat is a great recovery stock to own as economies see a return to normal and COVID-19 no longer impacts demand for its products or disrupts the supply chain.\nIn 2019, the company's sales of $298 million were more than triple the $88 million it reported in 2018. And in 2020, sales rose further to $407 million but at a much lower growth rate of 37%. For the latest quarter ended Oct. 2, net revenue increased just 13% to $106 million -- and in the U.S. market, sales were actually down 14%. It was the company's international operations that kept the overall numbers in the green (rising by an impressive 143%).\nHowever, the company's performance should improve with a return to normalcy. In addition, Beyond Meat has new products and deals that could propel it to even greater heights than before. It is supplying fast-food giant McDonald's with the patty for its McPlant burger, which could be a boon for the business if it proves to be successful. Plus, it has a joint venture with soft-drink maker PepsiCo to develop new products. Beyond Meat also recently launched meatless chicken tenders.\nThings may look grim in the short term for Beyond Meat, but there are many catalysts out there that could make its stock price today look incredibly cheap in a year or two.","news_type":1,"symbols_score_info":{"DOCU":0.9,"JAZZ":0.9,"BYND":0.9}},"isVote":1,"tweetType":1,"viewCount":1959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875892565,"gmtCreate":1637630280003,"gmtModify":1637630280003,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875892565","repostId":"1171692239","repostType":2,"repost":{"id":"1171692239","kind":"news","pubTimestamp":1637582731,"share":"https://www.laohu8.com/m/news/1171692239?lang=zh_CN&edition=full","pubTime":"2021-11-22 20:05","market":"us","language":"en","title":"Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作,将其算法用于mRNA疫苗和疗法开发</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1171692239","media":"Reuters","summary":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its ","content":"<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.</p><p><blockquote>路透北京11月22日-中国科技巨头百度公司(9888.HK)周一表示,已将其信使RNA(mRNA)序列算法授权给赛诺菲公司,用于设计疫苗和治疗产品,这是其首个此类产品。与全球主要制药商达成商业协议。</blockquote></p><p> Sanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more</p><p><blockquote>赛诺菲(SASY.PA)在大流行之前一直是世界上最大的疫苗制造商之一,但这家法国公司在开发针对COVID-19的mRNA疫苗方面被竞争对手BioNTech/辉瑞(PFE.N)和Moderna(MRNA.O)击败。阅读更多</blockquote></p><p> Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.</p><p><blockquote>赛诺菲于9月停止了自己的mRNA COVID-19疫苗的试验,转而专注于与葛兰素史克(GSK.L)合作,将另一种基于更传统的蛋白质方法的COVID-19候选疫苗推向市场。</blockquote></p><p> The French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.</p><p><blockquote>这家法国集团表示,它将把其mRNA资源集中用于其他需求未得到满足的传染病和治疗方法。</blockquote></p><p> Baidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.</p><p><blockquote>领导该项目的百度科学家黄亮表示,当赛诺菲使用其算法发现的任何基于mRNA的疗法或候选疫苗进入临床试验时,百度将获得里程碑付款。</blockquote></p><p> \"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.</p><p><blockquote>“这项协议包括里程碑付款的事实表明,[赛诺菲]非常有信心将使用百度算法开发的候选药物带入临床试验并推向市场,”Huang告诉路透社。他拒绝透露交易规模。</blockquote></p><p> An mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.</p><p><blockquote>基于mRNA的疫苗含有mRNA序列,该序列指示人类细胞产生可以刺激免疫系统发挥作用的蛋白质。</blockquote></p><p> Baidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.</p><p><blockquote>黄说,百度的算法旨在提供大量优化的mRNA序列,有早期迹象表明,它可能比标准算法更适合疫苗和治疗药物开发。</blockquote></p><p> Specifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.</p><p><blockquote>特别是关于COVID-19候选疫苗,根据尚未通过的实验室研究和动物测试,那些含有百度算法生成的mRNA序列的疫苗更稳定,并且似乎比基于标准算法的基线注射需要更小的剂量。同行评审。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作,将其算法用于mRNA疫苗和疗法开发</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作,将其算法用于mRNA疫苗和疗法开发</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-22 20:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.</p><p><blockquote>路透北京11月22日-中国科技巨头百度公司(9888.HK)周一表示,已将其信使RNA(mRNA)序列算法授权给赛诺菲公司,用于设计疫苗和治疗产品,这是其首个此类产品。与全球主要制药商达成商业协议。</blockquote></p><p> Sanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more</p><p><blockquote>赛诺菲(SASY.PA)在大流行之前一直是世界上最大的疫苗制造商之一,但这家法国公司在开发针对COVID-19的mRNA疫苗方面被竞争对手BioNTech/辉瑞(PFE.N)和Moderna(MRNA.O)击败。阅读更多</blockquote></p><p> Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.</p><p><blockquote>赛诺菲于9月停止了自己的mRNA COVID-19疫苗的试验,转而专注于与葛兰素史克(GSK.L)合作,将另一种基于更传统的蛋白质方法的COVID-19候选疫苗推向市场。</blockquote></p><p> The French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.</p><p><blockquote>这家法国集团表示,它将把其mRNA资源集中用于其他需求未得到满足的传染病和治疗方法。</blockquote></p><p> Baidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.</p><p><blockquote>领导该项目的百度科学家黄亮表示,当赛诺菲使用其算法发现的任何基于mRNA的疗法或候选疫苗进入临床试验时,百度将获得里程碑付款。</blockquote></p><p> \"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.</p><p><blockquote>“这项协议包括里程碑付款的事实表明,[赛诺菲]非常有信心将使用百度算法开发的候选药物带入临床试验并推向市场,”Huang告诉路透社。他拒绝透露交易规模。</blockquote></p><p> An mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.</p><p><blockquote>基于mRNA的疫苗含有mRNA序列,该序列指示人类细胞产生可以刺激免疫系统发挥作用的蛋白质。</blockquote></p><p> Baidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.</p><p><blockquote>黄说,百度的算法旨在提供大量优化的mRNA序列,有早期迹象表明,它可能比标准算法更适合疫苗和治疗药物开发。</blockquote></p><p> Specifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.</p><p><blockquote>特别是关于COVID-19候选疫苗,根据尚未通过的实验室研究和动物测试,那些含有百度算法生成的mRNA序列的疫苗更稳定,并且似乎比基于标准算法的基线注射需要更小的剂量。同行评审。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/\">Reuters</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09888":"百度集团-SW","BIDU":"百度","SNYNF":"Sanofi"},"source_url":"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171692239","content_text":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.\nSanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more\nSanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.\nThe French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.\nBaidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.\n\"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.\nAn mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.\nBaidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.\nSpecifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.","news_type":1,"symbols_score_info":{"BIDU":0.9,"09888":0.9,"SNYNF":0.9}},"isVote":1,"tweetType":1,"viewCount":2400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876512628,"gmtCreate":1637331273530,"gmtModify":1637331273657,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876512628","repostId":"1144455380","repostType":4,"repost":{"id":"1144455380","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637328728,"share":"https://www.laohu8.com/m/news/1144455380?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:32","market":"us","language":"en","title":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144455380","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S","content":"<p>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和BioNTech SE的股价在盘前交易中上涨约2%,此前它们获得了美国FDA扩大的加强剂紧急使用授权,将18岁及以上的个人纳入其中。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布,美国。美国食品药品监督管理局(FDA)已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权(EUA),以包括18岁及以上的个人。加强剂量将在主要系列完成后至少六个月施用,并且剂量强度与主要系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>董事长Albert Bourla表示:“随着我们抗击COVID-19的斗争接近两年,我们达到了另一个重要里程碑,扩大了对18岁及以上人群的COVID-19疫苗加强剂量的授权。”辉瑞公司主席兼首席执行官。“有了加强剂,更多的成年人现在将有机会帮助保持针对这种疾病的高水平保护。我们感谢FDA的严格审查,以及今天采取的行动,我们希望这将有助于加速我们走出这场大流行。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>BioNTech首席执行官兼联合创始人Ugur Sahin医学博士表示:“今天FDA的决定得到了临床数据的支持,这些数据显示,我们的疫苗加强剂量后产生了强大的免疫反应,甚至超过了高效的两剂主要计划完成后的免疫反应。”“这些数据表明,我们疫苗的加强剂量有可能对包括Delta在内的经过测试的变种保持高水平的保护。”</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10月,两家公司宣布了该试验的积极顶线结果,显示与未接受过辉瑞-BioNTech初级两剂系列的个人相比,对之前接受过辉瑞-BioNTech初级两剂系列的个人进行的加强剂量显示出95%的相对疫苗功效。到目前为止,这是第一个也是唯一一个从任何随机、对照的新冠肺炎疫苗加强试验中披露的疗效数据。不良事件概况与疫苗的其他临床安全性数据基本一致,未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在完成初级系列后紧急使用,用于65岁及以上的个人、18至64岁的严重新冠肺炎高风险个人、18至64岁经常在机构或职业中暴露于新型冠状病毒的个人,以及已完成不同授权新冠肺炎疫苗初级疫苗接种的合格个人。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和BioNTech根据与美国政府现有的供应协议继续供应疫苗,包括足够的疫苗剂量,该协议将持续至2022年4月。这些公司预计今天的消息不会影响与世界各地政府和国际卫生组织的现有供应协议。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和BioNTech SE的股价在盘前交易中上涨约2%,此前它们获得了美国FDA扩大的加强剂紧急使用授权,将18岁及以上的个人纳入其中。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布,美国。美国食品药品监督管理局(FDA)已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权(EUA),以包括18岁及以上的个人。加强剂量将在主要系列完成后至少六个月施用,并且剂量强度与主要系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>董事长Albert Bourla表示:“随着我们抗击COVID-19的斗争接近两年,我们达到了另一个重要里程碑,扩大了对18岁及以上人群的COVID-19疫苗加强剂量的授权。”辉瑞公司主席兼首席执行官。“有了加强剂,更多的成年人现在将有机会帮助保持针对这种疾病的高水平保护。我们感谢FDA的严格审查,以及今天采取的行动,我们希望这将有助于加速我们走出这场大流行。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>BioNTech首席执行官兼联合创始人Ugur Sahin医学博士表示:“今天FDA的决定得到了临床数据的支持,这些数据显示,我们的疫苗加强剂量后产生了强大的免疫反应,甚至超过了高效的两剂主要计划完成后的免疫反应。”“这些数据表明,我们疫苗的加强剂量有可能对包括Delta在内的经过测试的变种保持高水平的保护。”</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10月,两家公司宣布了该试验的积极顶线结果,显示与未接受过辉瑞-BioNTech初级两剂系列的个人相比,对之前接受过辉瑞-BioNTech初级两剂系列的个人进行的加强剂量显示出95%的相对疫苗功效。到目前为止,这是第一个也是唯一一个从任何随机、对照的新冠肺炎疫苗加强试验中披露的疗效数据。不良事件概况与疫苗的其他临床安全性数据基本一致,未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在完成初级系列后紧急使用,用于65岁及以上的个人、18至64岁的严重新冠肺炎高风险个人、18至64岁经常在机构或职业中暴露于新型冠状病毒的个人,以及已完成不同授权新冠肺炎疫苗初级疫苗接种的合格个人。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和BioNTech根据与美国政府现有的供应协议继续供应疫苗,包括足够的疫苗剂量,该协议将持续至2022年4月。这些公司预计今天的消息不会影响与世界各地政府和国际卫生组织的现有供应协议。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144455380","content_text":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.\n\nPfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\n“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”\nIn October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.\nA booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.\nPfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871904658,"gmtCreate":1637016989498,"gmtModify":1637016989498,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"[OMG] ","listText":"[OMG] ","text":"[OMG]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871904658","repostId":"1172705595","repostType":4,"isVote":1,"tweetType":1,"viewCount":4024,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857874840,"gmtCreate":1635519984474,"gmtModify":1635519984474,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573647345754035","authorIdStr":"3573647345754035"},"themes":[],"htmlText":"Yes!","listText":"Yes!","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/857874840","repostId":"2179105882","repostType":4,"isVote":1,"tweetType":1,"viewCount":3308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}